Current and historical daily PE Ratio for Nath Bio-Genes (India) Ltd (
BOM:537291
) from 2014 to Jun 25 2024. The price to earnings ratio is calculated by taking the current stock price and dividing it by the most recent trailing twelve-month earnings per share (EPS) number. The data is updated every 20 minutes during market hours. The PE ratio can be viewed as the number of years it takes for the company to earn back the price you pay for the stock. Therefore, lower-P/E stocks are more attractive than higher P/E stocks so long as the PE ratio is positive. Also for stocks with the same PE ratio, the one with faster growth business is more attractive. Nath Bio-Genes (India) stock (BOM:537291) PE ratio as of Jun 25 2024 is 10.
More Details
Nath Bio-Genes (India) Ltd (BOM:537291) PE Ratio (TTM) Chart
Nath Bio-Genes (India) Ltd (BOM:537291) PE Ratio (TTM) Historical Data
View and export this data going back to 2014. Start your Free Trial
Total 1246
- 1
- 2
- 3
- 4
- 5
- 6
- 14
Nath Bio-Genes (India) PE Ratio (TTM) Historical Data | |||
---|---|---|---|
Date | PE Ratio (TTM) Data | Date | PE Ratio (TTM) Data |
2024-06-25 | 9.9 | 2024-04-16 | 9.0 |
2024-06-24 | 9.9 | 2024-04-15 | 9.0 |
2024-06-21 | 10.0 | 2024-04-12 | 9.4 |
2024-06-20 | 9.9 | 2024-04-10 | 9.2 |
2024-06-19 | 9.6 | 2024-04-09 | 9.0 |
2024-06-18 | 9.5 | 2024-04-08 | 9.2 |
2024-06-14 | 9.8 | 2024-04-05 | 9.1 |
2024-06-13 | 9.7 | 2024-04-04 | 9.2 |
2024-06-12 | 9.7 | 2024-04-03 | 9.2 |
2024-06-11 | 9.7 | 2024-04-02 | 9.0 |
2024-06-10 | 9.5 | 2024-04-01 | 8.7 |
2024-06-07 | 9.2 | 2024-03-28 | 8.3 |
2024-06-06 | 9.0 | 2024-03-27 | 8.4 |
2024-06-05 | 8.8 | 2024-03-26 | 8.5 |
2024-06-04 | 8.2 | 2024-03-22 | 8.7 |
2024-06-03 | 8.9 | 2024-03-21 | 8.5 |
2024-05-31 | 8.8 | 2024-03-20 | 8.5 |
2024-05-29 | 8.8 | 2024-03-19 | 8.4 |
2024-05-28 | 8.8 | 2024-03-18 | 8.6 |
2024-05-27 | 9.0 | 2024-03-14 | 8.8 |
2024-05-24 | 9.1 | 2024-03-13 | 8.5 |
2024-05-23 | 9.2 | 2024-03-12 | 9.0 |
2024-05-22 | 9.1 | 2024-03-11 | 8.9 |
2024-05-21 | 9.2 | 2024-03-07 | 9.2 |
2024-05-17 | 9.3 | 2024-03-06 | 9.2 |
2024-05-16 | 9.1 | 2024-03-05 | 9.5 |
2024-05-15 | 9.0 | 2024-03-04 | 9.5 |
2024-05-14 | 8.9 | 2024-03-01 | 9.8 |
2024-05-13 | 8.9 | 2024-02-29 | 9.6 |
2024-05-10 | 9.1 | 2024-02-28 | 9.7 |
2024-05-09 | 9.3 | 2024-02-27 | 10.0 |
2024-05-08 | 9.8 | 2024-02-26 | 10.2 |
2024-05-07 | 9.5 | 2024-02-23 | 10.0 |
2024-05-06 | 9.5 | 2024-02-22 | 10.0 |
2024-05-03 | 9.6 | 2024-02-21 | 10.0 |
2024-05-02 | 9.8 | 2024-02-20 | 10.2 |
2024-04-30 | 9.9 | 2024-02-19 | 10.3 |
2024-04-29 | 10.0 | 2024-02-16 | 10.3 |
2024-04-26 | 9.9 | 2024-02-15 | 10.1 |
2024-04-25 | 9.5 | 2024-02-14 | 10.1 |
2024-04-24 | 9.5 | 2024-02-13 | 9.9 |
2024-04-23 | 9.6 | 2024-02-12 | 9.7 |
2024-04-22 | 9.5 | 2024-02-09 | 10.2 |
2024-04-19 | 9.1 | 2024-02-08 | 10.5 |
2024-04-18 | 9.1 | 2024-02-07 | 10.6 |
Nath Bio-Genes (India) Ltd (BOM:537291) PE Ratio (TTM) Comparison
Company | Market Cap(Mil) | PE Ratio (TTM) |
---|
Business Description
Business Description
Nath Bio-Genes (India) Ltd
ISIN : INE448G01010
Compare
Compare
Traded in other countries / regions
NATHBIOGEN.India IPO Date
2014-01-28Description
Nath Bio-Genes (India) Ltd is engaged in the business of production, processing, and marketing of Hybrid and GM seeds. The company has a product range of field crops, vegetable crops, and micronutrient supplements. It has developed products across verticals of cotton, paddy, mustard, maize, okra, tomato, gourds, chili, and crop nutrition supplements. The operating segments of the group are Agriculture activities and Trading activities, of which a majority of revenue is derived from the Agriculture activities segment. Geographically, the group has a business presence in India and other countries, of which key revenue is generated within India.